Table 2.
Treatment | IL-1α | IL-1β | IL-4 | IL-5 | IL-6 | IL-8 | IL-10 | IL-13 | IL-17A | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBS vs. auto | ns | 0.23 | ns | 0.59 | ** | 0.01 | **** | <0.0001 | ns | 0.72 | ns | 0.2 | ns | 0.36 | ns | 0.61 | **** | <0.0001 |
FBS vs. Allo | ns | 0.3 | ns | 0.78 | ** | 0.01 | **** | <0.0001 | ns | 0.28 | ns | 0.16 | ns | 0.36 | ns | 0.54 | **** | <0.0001 |
Auto vs. Allo | ns | 0.98 | ns | 0.93 | ns | >0.99 | ns | 0.48 | ns | 0.65 | ns | 0.98 | ns | >0.99 | ns | 0.99 | ns | 0.09 |
Treatment | FGF-2 | Eotaxin | G-CSF | GM-CSF | Fractalkine | IP-10 | GRO | TNF-α | RANTES | |||||||||
FBS vs. auto | ns | 0.36 | * | 0.02 | ns | 0.63 | *** | 0.0003 | ns | 0.24 | ns | 0.39 | ns | 0.41 | ns | 0.21 | * | 0.02 |
FBS vs. Allo | * | 0.02 | * | 0.02 | ns | 0.63 | *** | 0.0002 | ns | 0.06 | ns | 0.64 | ns | 0.42 | ns | 0.36 | *** | 0.0006 |
Auto vs. Allo | ns | 0.14 | ns | >0.99 | ns | >0.99 | ns | 0.68 | ns | 0.49 | ns | 0.12 | ns | 0.99 | ns | 0.91 | * | 0.02 |
Statistical significance was indicated as
P ≤ 05,
P ≤ 01,
P ≤ 001,
P ≤ 0001.